Search:
MS Topics
Diagnosis Classification
Management of MS
Disease Modifying Agents
Imaging in MS
Clinical Trials in MS
Expert Exchange
Calendar of Events
Faculty
MSLeaders Home
Practice Profiles
Pharmacist Center
Nurse Center
Register for Updates
Understanding MS
 
Pharmacist Center provides a series of online CE Expert Discussions and relevant Case Studies presented by thought leaders in the field. These programs address important issues in the diagnosis, treatment and management of patients with MS. Each program provides 1 CE credit. Please join us for these educational programs.

You are also invited to review archived questions and answers as well as present your own clinical challenges to experts, who will directly respond to your queries. For questions and answers, please join us at the Experts Exchange.

Using Motivational Interviewing Techniques in the Care of the
Multiple Sclerosis Patient (9/05)
Featured Panelists
  • Ken Resnicow, PhD (Moderator)
  • Deanna Broujos
  • Celeste Egan
  • April M. Hopper, PharmD
  • Faith Reilly, RN
Click Here to Proceed to Program
The Role of Managed Care in the Use of Disease-Modifying Therapies in Multiple Sclerosis (MS) (12/04)
Featured Panelists
  • Howard S. Rossman, DO
  • Debra J. Stern, RPh
  • Sheldon J. Rich, RPh, PhD
Click Here to Proceed to Program
Cost-Effective Management of Multiple Sclerosis (MS) (11/04)
Featured Panelists
  • Howard S. Rossman, DO
  • Debra J. Stern, RPh
  • Sheldon J. Rich, RPh, PhD
Click Here to Proceed to Program
Selective Adhesion Molecule (SAM) Inhibitors in Multiple Sclerosis (8/04) 
Featured Panelists
  • Peter Calabresi, MD
  • J. Theodore Phillips, MD, PhD
  • Richard Rudick, MD
Click Here to Proceed to Program
Current Pharmacy Concepts in MS: Conversations and Case Studies
Current Concepts in Diagnosis and Treatment of MS (6/04)
The Benefit of Therapy for Multiple Sclerosis (11/04)
Persistence in Therapy for Multiple Sclerosis (11/04)

Featured Panelists
  • Colleen E. Miller, RN, NP, DNS
  • Marie A. Namey, RN, MSN
  • Heidi J. Crayton, MD
The Implications of Natalizumab for
Multiple Sclerosis (MS) Therapy (1/05) & (2/05)
Featured Panelists
  • J. Theodore Phillips, MD, PhD
  • Shirley O'Leary, RN, MSCN
  • Julie Farace, RN, BSN
  • Frederick E. Munschauer, MD
  • Mariko Kita, MD
Click Here to Proceed to Program
Search: